Vertex Pharmaceuticals to acquire Alpine Immune Sciences in $4.9 billion deal
Vertex Pharmaceuticals Incorporated (VRTX) has announced its plans to acquire Alpine Immune Sciences, Inc. (ALPN), a company dedicated to the discovery and development of novel...
LCT to benefit from Semma Therapeutics acquisition by Vertex
AUCKLAND: Living Cells Technologies (LCT) holds 121,995 shares in Semma Therapeutics, worth an anticipated USD 838,105 which would be realised on Vertex Pharmaceuticals Incorporated completing...